Market Tracker

05/24 8:33am ET

Alkermes Plc (NASDAQ:ALKS)

Thursday’s Trading Day
33.00 +1.25 / +3.94%
Data as of May 23
Day’s Change
Friday’s Pre-Market   Switch to standard view »
33.02 +0.02 / +0.06%
 
Volume: 1.0K

Today’s Trading

Previous close31.75
Today’s open30.10
Day’s range-- - --
Volume2,452,706
Average volume (3 months)1,345,360
Market cap$4.4B
Dividend yield--
Data as of 4:00pm ET, 05/23/2013

Growth & Valuation

Earnings growth (last year)-106.25%
Earnings growth (this year)--
Earnings growth (next 5 years)+65.79%
Revenue growth (last year)+108.95%
P/E ratioNM
Price/Sales5.46
Price/Book5.03

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc+0.20+0.57%
IDXXIDEXX Laboratories I...+1.11+1.33%
ENDPEndo Health Solution...+0.66+1.96%
WCRXWarner Chilcott Plc-0.25-1.23%
Data as of 4:00pm ET, 05/23/2013

Financials

Last reporting dateMay 20, 2013
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$390.0M
Annual profit (last year)-$113.7M
Net profit margin-29.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane Cooke
Corporate headquarters
Dublin, Dublin

Forecasts